BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16286571)

  • 21. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts.
    Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H
    Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GTP cyclohydrolase I/BH4 pathway protects EPCs via suppressing oxidative stress and thrombospondin-1 in salt-sensitive hypertension.
    Xie HH; Zhou S; Chen DD; Channon KM; Su DF; Chen AF
    Hypertension; 2010 Dec; 56(6):1137-44. PubMed ID: 21059996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice.
    Kundu S; Kumar M; Sen U; Mishra PK; Tyagi N; Metreveli N; Lominadze D; Rodriguez W; Tyagi SC
    J Cell Biochem; 2009 Jan; 106(1):119-26. PubMed ID: 19021146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats.
    Ghosh M; Wang HD; McNeill JR
    Br J Pharmacol; 2004 Feb; 141(4):562-73. PubMed ID: 14744820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP.
    Jia Z; Aoyagi T; Yang T
    Hypertension; 2010 Feb; 55(2):539-46. PubMed ID: 20065149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple Sclerosis Drug Fingolimod Induces Thrombotic Microangiopathy in Deoxycorticosterone Acetate/Salt Hypertension.
    Iwazu Y; Muto S; Ioka T; Watanabe Y; Iwazu K; Kusano E; Nagata D
    Hypertension; 2018 Sep; 72(3):776-784. PubMed ID: 30354753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia.
    Ellis EA; Sengupta N; Caballero S; Guthrie SM; Mames RN; Grant MB
    Antioxid Redox Signal; 2005; 7(11-12):1413-22. PubMed ID: 16356104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
    Wenceslau CF; Rossoni LV
    J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Zarzuelo MJ; Galindo P; Quintela AM; López-Sepúlveda R; Romero M; Tamargo J; Vargas F; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Jan; 52(1):70-9. PubMed ID: 22001745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice.
    Cao HJ; Fang J; Zhang YL; Zou LX; Han X; Yang J; Yan X; Li PB; Wang HX; Guo SB; Li HH
    J Mol Cell Cardiol; 2019 Dec; 137():34-45. PubMed ID: 31629736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.
    Yang XP; Liu YH; Shesely EG; Bulagannawar M; Liu F; Carretero OA
    Hypertension; 1999 Jul; 34(1):24-30. PubMed ID: 10406819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.
    Henderson BC; Sen U; Reynolds C; Moshal KS; Ovechkin A; Tyagi N; Kartha GK; Rodriguez WE; Tyagi SC
    Int J Biol Sci; 2007 Sep; 3(6):385-92. PubMed ID: 17848984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt model.
    Gürgen D; Kusch A; Klewitz R; Hoff U; Catar R; Hegner B; Kintscher U; Luft FC; Dragun D
    Hypertension; 2013 Mar; 61(3):730-6. PubMed ID: 23339165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tetrahydrobiopterin improves left ventricular diastolic function possibly through upregulating phosphorylated protein kinase B expression in hypertensive mice induced by deoxycorticosterone acetate].
    Wang QY; Yang MN; Xu H; Zhao Y; Lin X; Zhang XW; Zhao F; Zhao X; Kou XQ; Bai F; Yu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):759-765. PubMed ID: 27667273
    [No Abstract]   [Full Text] [Related]  

  • 37. Inducible NO synthase is constitutively expressed in porcine myocardium and its level decreases along with tachycardia-induced heart failure.
    Paslawska U; Kiczak L; Bania J; Paslawski R; Janiszewski A; Dzięgiel P; Zacharski M; Tomaszek A; Michlik K
    Cardiovasc Pathol; 2016; 25(1):3-11. PubMed ID: 26361649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
    Karatas A; Hegner B; de Windt LJ; Luft FC; Schubert C; Gross V; Akashi YJ; Gürgen D; Kintscher U; da Costa Goncalves AC; Regitz-Zagrosek V; Dragun D
    Hypertension; 2008 Apr; 51(4):1177-83. PubMed ID: 18259006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice.
    Leonard AM; Chafe LL; Montani JP; Van Vliet BN
    Am J Hypertens; 2006 Dec; 19(12):1264-9. PubMed ID: 17161773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.